VC  Hale BioPharma Ventures ocks/private/snapshot.asp?privcapId=60482104

     Office Locations:

1042-B North El Camino Real, Suite 430
Encinitas, CA 92024
Phone: 858-756-2480
Fax: 858-756-3567



  • Seed



  • Life Sciences & Healthcare



    Founded 2005, Hale BioPharma Ventures is a private company focused on the formation and development of biotechnology and specialty pharma companies. The firm is led by David Hale, who was previously President and CEO of CancerVax Corporation (which merged with Micromet, Inc.). Mr. Hale is a co-founder and Chairman of the Board of Somaxon Pharmaceuticals, Inc., and Chairman of Santarus, Inc., and Metabasis Therapeutics, which are publicly held companies. He also serves as Executive Chairman of privately held SkinMedica, Inc. and is a co-founder and director of Verus Pharmaceuticals, Inc., Conatus Pharmaceuticals, Inc., and Zogenix, Inc.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    David F. Hale Chairman and Chief Executive Officer


    Portfolio companies include:

      Conatus Pharmaceuticals
        web link

        web link


    Recent News: